Acute pulmonary lipopolysaccharide tolerance decreases TNF-α without reducing neutrophil recruitment

Journal of Immunology

Volumn 181, Issue 12, 2008, Pages 8402-8408

  Natarajan, Sudha ^a,b   Kim, Jiyoun ^a   Remick, Daniel G ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; LIPOPOLYSACCHARIDE; MESSENGER RNA; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; CYTOKINE; IMMUNOSUPPRESSIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; FEMALE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; LUNG LAVAGE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; ACUTE LUNG INJURY; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; COMPARATIVE STUDY; DISEASE MODEL; DOWN REGULATION; DRUG ANTAGONISM; ENDOTRACHEAL INTUBATION; IMMUNOLOGY; LUNG; METABOLISM; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PHYSIOLOGY;

ACUTE LUNG INJURY; ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FEMALE; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; INTUBATION, INTRATRACHEAL; LIPOPOLYSACCHARIDES; LUNG; MICE; MICE, INBRED BALB C; NEUTROPHIL INFILTRATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 58849099608     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.12.8402     Document Type: Article

References (49)

1. Miller, S. I., R. K. Ernst, and M. W. Bader. 2005. LPS, TLR4 and infectious disease diversity. Nat. Rev. Microbiol. 3: 36-46.
2. Bosshart, H., and M. Heinzelmann. 2007. Targeting bacterial endotoxin: two sides of a coin. Ann. NY Acad. Sci. 1096: 1-17.
3. Yamada, H., S. Mizuno, A. C. Ross, and I. Sugawara. 2007. Retinoic acid therapy attenuates the severity of tuberculosis while altering lymphocyte and macrophage numbers and cytokine expression in rats infected with Mycobacterium tuberculosis. J. Nutr. 137: 2696-2700.
4. Tracey, K. J., H. Wei, K. R. Manogue, Y. Fong, D. G. Hesse, H. T. Nguyen, G. C. Kuo, B. Beutler, R. S. Cotran, A. Cerami, et al. 1988. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J. Exp. Med. 167: 1211-1227.
5. Foster, S. L., D. C. Hargreaves, and R. Medzhitov. 2007. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447: 972-978.
6. Fraker, D. L., M. C. Stovroff, M. J. Merino, and J. A. Norton. 1988. Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity. J. Exp. Med. 168: 95-105. (Pubitemid 18195137)
7. Zeisberger, E., and J. Roth. 1998. Tolerance to pyrogens. Ann. NY Acad. Sci. 856: 116-131.
8. Wheeler, D. S., P. M. Lahni, A. G. Denenberg, S. E. Poynter, H. R. Wong, J. A. Cook, and B. Zingarelli. 2008. Induction of endotoxin tolerance enhances bacterial clearance and survival in murine polymicrobial sepsis. Shock 30: 267-273.
9. Medvedev, A. E., I. Sabroe, J. D. Hasday, and S. N. Vogel. 2006. Tolerance to microbial TLR ligands: molecular mechanisms and relevance to disease. J. Endotoxin Res. 12: 133-150. (Pubitemid 47487520)
10. Sinistro, A., C. Ciaprini, S. Natoli, E. Sussarello, F. C. Carducci, C. Almerighi, M. Capozzi, F. Bolacchi, G. Rocchi, and A. Bergamini. 2007. Lipopolysaccharide desensitizes monocytes-macrophages to CD40 ligand stimulation. Immunology 122: 362-370.
11. Mathison, J. C., G. D. Virca, E. Wolfson, P. S. Tobias, K. Glaser, and R. J. Ulevitch. 1990. Adaptation to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages. J. Clin. Invest. 85: 1108-1118.
12. Mathison, J., E. Wolfson, S. Steinemann, P. Tobias, and R. Ulevitch. 1993. Lipopolysaccharide (LPS) recognition in macrophages: participation of LPS-binding protein and CD14 in LPS-induced adaptation in rabbit peritoneal exudate macrophages. J. Clin. Invest. 92: 2053-2059. (Pubitemid 23304577)
13. Ellaban, E., G. Bolgos, and D. Remick. 2004. Selective macrophage suppression during sepsis. Cell Immunol. 231: 103-111.
14. Heagy, W., C. Hansen, K. Nieman, M. Cohen, C. Richardson, J. L. Rodriguez, and M. A. West. 2000. Impaired ex vivo lipopolysaccharide-stimulated whole blood tumor necrosis factor production may identify "septic" intensive care unit patients. Shock 14: 271-276, discussion 276-277.
15. Thepen, T., K. Hoeben, J. Breve, and G. Kraal. 1992. Alveolar macrophages down-regulate local pulmonary immune responses against intratracheally administered T-cell-dependent, but not T-cell-independent antigens. Immunology 76: 60-64.
16. Holt, P. G., J. Oliver, N. Bilyk, C. McMenamin, P. G. McMenamin, G. Kraal, and T. Thepen. 1993. Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J. Exp. Med. 177: 397-407.
17. Bush, R. K., and D. B. Peden. 2006. Advances in environmental and occupational disorders. J. Allergy Clin. Immunol. 117: 1367-1373.
18. Schwartz, D. A., P. S. Thorne, S. J. Yagla, L. F. Burmeister, S. A. Olenchock, J. L. Watt, and T. J. Quinn. 1995. The role of endotoxin in grain dust-induced lung disease. Am. J. Respir. Crit. Care Med. 152: 603-608.
19. Michel, O., R. Ginanni, J. Duchateau, F. Vertongen, B. Le Bon, and R. Sergysels. 1991. Domestic endotoxin exposure and clinical severity of asthma. Clin. Exp. Allergy 21: 441-448.
20. Gavett, S. H., D. J. O'Hearn, X. Li, S. K. Huang, F. D. Finkelman, and M. Wills-Karp. 1995. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J. Exp. Med. 182: 1527-1536.
21. Nemzek, J. A., J. Siddiqui, and D. G. Remick. 2001. Development and optimization of cytokine ELISAs using commercial antibody pairs. J. Immunol. Methods 255: 149-157.
22. Giulietti, A., L. Overbergh, D. Valckx, B. Decallonne, R. Bouillon, and C. Mathieu. 2001. An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 25: 386-401. (Pubitemid 34164011)
23. Nemzek, J. A., S. J. Ebong, J. Kim, G. L. Bolgos, and D. G. Remick. 2002. Keratinocyte growth factor pretreatment is associated with decreased macrophage inflammatory protein-2α concentrations and reduced neutrophil recruitment in acid aspiration lung injury. Shock 18: 501-506.
24. Wollenberg, G. K., L. E. DeForge, G. Bolgos, and D. G. Remick. 1993. Differential expression of tumor necrosis factor and interleukin-6 by peritoneal macrophages in vivo and in culture. Am. J. Pathol. 143: 1121-1130. (Pubitemid 24070554)
25. Huey, K. A., R. H. McCusker, and K. W. Kelley. 2008. Exaggerated expression of skeletal muscle-derived interleukin-6, but not TNFα, in mice lacking interleukin- 10. J. Neuroimmunol. 199: 56-62.
26. Uhrig, A., R. Banafsche, M. Kremer, S. Hegenbarth, A. Hamann, M. Neurath, G. Gerken, A. Limmer, and P. A. Knolle. 2005. Development and functional consequences of LPS tolerance in sinusoidal endothelial cells of the liver. J. Leukocyte Biol. 77: 626-633. (Pubitemid 40628742)
27. Murphey, E. D., G. Fang, T. K. Varma, and E. R. Sherwood. 2007. Improved bacterial clearance and decreased mortality can be induced by LPS tolerance and is not dependent upon IFN-γ. Shock 27: 289-295.
28. Zuckerman, S. H., and N. Qureshi. 1992. In vivo inhibition of lipopolysaccharide- induced lethality and tumor necrosis factor synthesis by Rhodobacter sphaeroides diphosphoryl lipid A is dependent on corticosterone induction. Infect. Immun. 60: 2581-2587.
29. Freudenberg, M. A., and C. Galanos. 1988. Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages. Infect. Immun. 56: 1352-1357.
30. De Creus, A., M. Abe, A. H. Lau, H. Hackstein, G. Raimondi, and A. W. Thomson. 2005. Low TLR4 expression by liver dendritic cells correlates with reduced capacity to activate allogeneic T cells in response to endotoxin. J. Immunol. 174: 2037-2045.
31. Khan, A. J., and R. Nanchal. 2007. Cotton dust lung diseases. Curr. Opin. Pulm. Med. 13: 137-141.
32. Castellan, R. M., S. A. Olenchock, K. B. Kinsley, and J. L. Hankinson. 1987. Inhaled endotoxin and decreased spirometric values: an exposure-response relation for cotton dust. N. Engl. J. Med. 317: 605-610.
33. Eisenbarth, S. C., D. A. Piggott, J. W. Huleatt, I. Visintin, C. A. Herrick, and K. Bottomly. 2002. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J. Exp. Med. 196: 1645-1651.
34. Kim, Y. K., S. Y. Oh, S. G. Jeon, H. W. Park, S. Y. Lee, E. Y. Chun, B. Bang, H. S. Lee, M. H. Oh, Y. S. Kim, et al. 2007. Airway exposure levels of lipopolysaccharide determine type 1 versus type 2 experimental asthma. J. Immunol. 178: 5375-5382.
35. Fitting, C., S. Dhawan, and J. M. Cavaillon. 2004. Compartmentalization of tolerance to endotoxin. J. Infect. Dis. 189: 1295-1303.
36. Kallapur, S. G., A. H. Jobe, M. K. Ball, I. Nitsos, T. J. Moss, N. H. Hillman, J. P. Newnham, and B. W. Kramer. 2007. Pulmonary and systemic endotoxin tolerance in preterm fetal sheep exposed to chorioamnionitis. J. Immunol. 179: 8491-8499.
37. Perzanowski, M. S., R. L. Miller, P. S. Thorne, R. G. Barr, A. Divjan, B. J. Sheares, R. S. Garfinkel, F. P. Perera, I. F. Goldstein, and G. L. Chew. 2006. Endotoxin in inner-city homes: associations with wheeze and eczema in early childhood. J. Allergy Clin. Immunol. 117: 1082-1089.
38. McKinley, L., J. Kim, G. L. Bolgos, J. Siddiqui, and D. G. Remick. 2004. Reproducibility of a novel model of murine asthma-like pulmonary inflammation. Clin. Exp. Immunol. 136: 224-231. (Pubitemid 38543439)
39. Van Zee, K. J., T. Kohno, E. Fischer, C. S. Rock, L. L. Moldawer, and S. F. Lowry. 1992. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor α in vitro and in vivo. Proc. Natl. Acad. Sci. USA 89: 4845-4849.
40. Deng, J. C., G. Cheng, M. W. Newstead, X. Zeng, K. Kobayashi, R. A. Flavell, and T. J. Standiford. 2006. Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M. J. Clin. Invest. 116: 2532-2542.
41. van 't Veer, C., P. S. van den Pangaart, M. A. van Zoelen, M. de Kruif, R. S. Birjmohun, E. S. Stroes, A. F. de Vos, and T. van der Poll. 2007. Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model. J. Immunol. 179: 7110-7120.
42. Curtis, J. R., N. Patkar, A. Xie, C. Martin, J. J. Allison, M. Saag, D. Shatin, and K. G. Saag. 2007. Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor α antagonists. Arthritis Rheum. 56: 1125-1133. (Pubitemid 46608637)
43. Rennard, S. I., C. Fogarty, S. Kelsen, W. Long, J. Ramsdell, J. Allison, D. Mahler, C. Saadeh, T. Siler, P. Snell, et al. 2007. The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 175: 926-934. (Pubitemid 46684703)
44. Zink, A., and J. Listing. 2007. Risk of serious bacterial infection: treatment with anti-TNF versus methotrexate. Nat. Clin. Pract. Rheumatol. 3: 546-547. (Pubitemid 47506010)
45. Rijneveld, A. W., S. Florquin, T. Hartung, P. Speelman, and T. van der Poll. 2003. Anti-tumor necrosis factor antibody impairs the therapeutic effect of ceftriaxone in murine pneumococcal pneumonia. J. Infect. Dis. 188: 282-285.
46. Deveci, F., M. H. Muz, N. Ilhan, G. Kirkil, T. Turgut, and N. Akpolat. 2008. Evaluation of the anti-inflammatory effect of infliximab in a mouse model of acute asthma. Respirology 13: 488-497. (Pubitemid 351725276)
47. Kim, J., L. McKinley, S. Natarajan, G. L. Bolgos, J. Siddiqui, S. Copeland, and D. G. Remick. 2006. Anti-tumor necrosis factor-α antibody treatment reduces pulmonary inflammation and methacholine hyper-responsiveness in a murine asthma model induced by house dust. Clin. Exp. Allergy 36: 122-132.
48. Gehring, U., W. Bischof, B. Fahlbusch, H. E. Wichmann, and J. Heinrich. 2002. House dust endotoxin and allergic sensitization in children. Am. J. Respir. Crit. Care Med. 166: 939-944. (Pubitemid 35193222)
49. von Mutius, E., C. Braun-Fahrlander, R. Schierl, J. Riedler, S. Ehlermann, S. Maisch, M. Waser, and D. Nowak. 2000. Exposure to endotoxin or other bacterial components might protect against the development of atopy. Clin. Exp. Allergy 30: 1230-1234.